Intervention
High Intensity Interval Training
ClinicalTrials.gov intervention label
Clinical trials
16 shownComparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic PatientsNCT07484399 · 2026-03-05
NOT_YET_RECRUITINGEffect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive PatientsNCT07188272 · 2025-07-10
COMPLETEDAdjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer PatientsNCT05156372 · 2023-12-01
WITHDRAWNCorrelation of Anti-gravity Muscle Strength With Glycemic Control, Duration of Disease, and Neuropathy Severity in Type 2 Diabetes Mellitus.NCT05873478 · 2023-02-06
COMPLETEDHigh-Intensity Interval Training and Regulatory T CellsNCT04774484 · 2023-01-01
WITHDRAWNVLCD & Adjuvant Exercise Effect in Overweight Diabetic MenNCT04957589 · 2020-01-01
COMPLETEDTime-restricted Eating and High Intensity Interval Training Among WomenNCT04019860 · 2019-08-12
COMPLETEDPhysiological Benefits of High-intensity Interval Training for Individuals With Parkinson's DiseaseNCT03940261 · 2019-06-12
COMPLETEDEssential Amino Acids and High Intensity Interval TrainingNCT04080102 · 2019-03-01
COMPLETEDREPLACE: Can Exercise Replace Inhaled Corticosteroid Treatment in Asthma? A RCTNCT03290898 · 2017-10-13
COMPLETEDPROstaTe Cancer - Exercise-STudy (PRO-TEST)NCT02954783 · 2016-11-01
COMPLETEDHigh Intensity Interval Training for People With Mild Multiple Sclerosis: A Feasibility StudyNCT02702804 · 2016-04-21
COMPLETEDHigh-Intensity Interval Training on Pre-Hypertensive SubjectsNCT03000140 · 2015-03-01
COMPLETEDHigh-Intensity Exercise and Endothelial Function in Type 1 Diabetes(HIIT-T1D)NCT03451201 · 2015-01-01
COMPLETEDHigh Intensity Interval Training Versus Moderate Continuous Training in Heart Failure With Preserved Ejection FractionNCT02916225 · 2014-06-01
COMPLETEDHigh Intensity Interval Versus Continuous Moderate Intensity Training: Maximizing the Benefits of Exercise in Overweight AdolescentsNCT01935323 · 2013-02-01
COMPLETEDCommon conditions
Hypertension2Arterial Stiffness1Asthma1Cardiovascular Risk Factor1Castrate Resistant Prostate Cancer1Cognitive Flexibility Among Female Teenagers1Diabetes Mellitus Type 2 in Obese1Diastolic Heart Failure1End Stage Renal Disease1Endothelial Dysfunction1Exercise Training1Heart Failure1Metabolism1Metabolism Disorder1Metastatic Prostate Adenocarcinoma1Metastatic Prostate Cancer1Multiple Sclerosis1Obesity1Obesity; Endocrine1Parkinson Disease1Physical Fitness1Prostate Cancer1Prostate Cancer Metastatic1Type 1 Diabetes Mellitus1Type 2 Diabetes Mellitus With Complication1
Leading sponsors
Hospital de Clinicas de Porto Alegre2Riphah International University2Bispebjerg Hospital1Copenhagen University Hospital, Rigshospitalet1Deraya University1Francesc Marti1Norwegian University of Science and Technology1Sheffield Teaching Hospitals NHS Foundation Trust1The University of Texas Health Science Center at San Antonio1Universidad Santo Tomas1University of Alabama at Birmingham1University of Guelph1University of North Carolina, Chapel Hill1University of Nottingham1
Trial status mix
COMPLETED13
WITHDRAWN2
NOT_YET_RECRUITING1
Phase mix
NA15
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.